PUBLIC COMPANY
saveGenentech Inc
updated 1mo ago
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It operates as an independent subsidiary of holding company Roche. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
community read0 votes
pipeline
40
marketed
23
phase 3
2
catalysts ytd
9
approvals ytd
9
recalls ytd
0
Pipeline(40)
view full pipeline →pipeline depth40 products
4Phase 22Phase 323Marketed10Unknown1pre_registration
Marketed
(atezolizumab + hyaluronidase (human recombinant))
Hepatocellular Carcinoma
Marketed(hyaluronidase (human recombinant) + ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Marketed(hyaluronidase (recombinant human) + pertuzumab + trastuzumab)
Human Epidermal Growth Factor Receptor 2 Positive Breast…
Marketed(hyaluronidase (recombinant, human) + rituximab)
Chronic Lymphocytic Leukemia (CLL)
Marketed(hyaluronidase (recombinant, human) + trastuzumab)
Breast Cancer
Upcoming
no upcoming catalysts on record
Recent(90d)
approval (2)
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that